Triamcinolone Acetonide Injection, Suspension
Product Images NDC 0703-0243

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Triamcinolone Acetonide (NDC 0703-0243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

1 (Image 2)

FDA Label Image

1 (Image 3)

Triamcinolone Acetonide Injectable Suspension USP is a medication used for intramuscular or intra-articular use only. Each 5 mL multiple-dose vial provides 200 mg of Triamcinolone Acetonide at a concentration of 40 mg per mL. The medication comes with a serialization flap and should be stored in a cool and dry place. The suspension contains sodium hyaluronate as a viscous agent and carboxymethylcellulose as a suspending agent. It is manufactured in Zagred, Croatia, by Pivainatsa. Dosage instructions are available on request.*

FDA Label Image

1 (Image 4)

This is a description of a medication product. It is for a treatment that contains Triamcinolone Acetonide and Beclomethasone Dipropionate, and is manufactured in a 10 mL Multiple-Dose Vial. The medication is an Injectable Suspension USP, intended for intramuscular or intra-articular use only and comes with dosage information. The medication provides 40 mg tiamcinlone Streal and 0565% sodum chorde USP. The product is manufactured by Teva Pharmaceuticals USA, located in Horh Wales, PA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.